The General Introduction of Adenovirus Packaging
Synbio Technologies provides Adenovirus Packaging Services for rapid and efficient gene transfection across a wide range of cell types, including primary cells that are challenging to transfect. Our adenoviral packaging system can accommodate large gene fragments and ensures high-level expression of target genes, making it ideal for various experimental studies.
Highlights
-
- High Viral Titers
-
- Low Disruption Risk to The Host Genome
-
- High-efficiency in Gene Delivery Both In Vitro And In Vivo
-
- Ability to Infect Both Dividing & Non-dividing Cells
Service Details
Adenovirus Packaging
|
Service Types
|
Titer
|
Volume
|
Turnaround Time
|
RNAi Adenovirus
|
1*1010 PFU/ml or1*1011 PFU/ml
|
1ml
|
50-55 Business Days
|
sgRNA Adenovirus
|
1*1010 PFU/ml or1*1011 PFU/ml
|
Overexpression Adenovirus
|
1*1010 PFU/ml or1*1011 PFU/ml
|
Deliverables
-
Free control virus
-
Virus liquid, ≥1010 PFU/ml, 200 μL/tube
-
QC report
FAQs
The key components needed for adenovirus packaging include:
- Adenoviral vector plasmids: These contain the genetic material to be delivered.
- Packaging cell lines: These cells support the production of adenoviral particles.
- Helper plasmids: These provide necessary adenoviral genes that are not included in the vector plasmid but are required for virus production.
Biohazard risks: Adenoviruses can be pathogenic. Proper containment and safety protocols are essential.
Immunogenicity: The adenoviral vector can trigger immune responses in the host.
Insertional mutagenesis: The integration of vector DNA into the host genome could potentially cause harmful effects.
Gene therapy: Correcting defective genes or adding new genes to treat genetic disorders.
Cancer therapy: Delivering therapeutic genes to target and kill cancer cells.
Vaccines: Developing vaccines by expressing antigens from pathogens to stimulate an immune response.
Get in Touch with Us
Related Services